Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity

.

Source: Human Vaccines and Immunotherapeutics - June 15, 2020 Category: Allergy & Immunology Authors: Katherine Schultheis Holly M Pugh Janet Oh Jacklyn Nguyen Bryan Yung Charles Reed Neil Cooch Jing Chen Jian Yan Kar Muthumani Laurent M. Humeau David B. Weiner Kate E. Broderick Trevor R. F. Smith Source Type: research